Substance Use Disorder Detection Rates Among Providers of General Medical Inpatients
- 27 October 2020
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 36 (3) , 668-675
Abstract
Background The prevalence of substance use disorders is higher among medical inpatients than in the general population, placing inpatient providers in a prime position to detect these patients and intervene. Objective To assess provider detection rates of substance use disorders among medical inpatients and to identify patient characteristics associated with detection. Design Data drawn from a cluster randomized controlled trial that tested the effectiveness of three distinct implementation strategies for providers to screen patients for substance use disorders and deliver a brief intervention (Clinical Trials.gov: NCT01825057). Participants A total of 1076 patients receiving care from 13 general medical inpatient units in a large teaching hospital participated in this study. Main Measures Data sources included patient self-reported questionnaires, a diagnostic interview for substance use disorders, and patient medical records. Provider detection was determined by diagnoses documented in medical records. Key Results Provider detection rates were highest for nicotine use disorder (72.2%) and lowest for cannabis use disorder (26.4%). Detection of alcohol use disorder was more likely among male compared to female patients (OR (95% CI) = 4.0 (1.9, 4.8)). When compared to White patients, alcohol (OR (95% CI) = 0.4 (0.2, 0.6)) and opioid (OR (95% CI) = 0.2 (0.1, 0.7)) use disorders were less likely to be detected among Black patients, while alcohol (OR (95% CI) = 0.3 (0.0, 2.0)) and cocaine (OR (95% CI) = 0.3 (0.1, 0.9)) use disorders were less likely to be detected among Hispanic patients. Providers were more likely to detect nicotine, alcohol, opioid, and other drug use disorders among patients with higher addiction severity (OR (95% CI) = 1.20 (1.08–1.34), 1.62 (1.48, 1.78), 1.46 (1.07, 1.98), 1.38 (1.00, 1.90), respectively). Conclusions Findings indicate patient characteristics, including gender, race, and addiction severity impact rates of provider detection. Instituting formal screening for all substances may increase provider detection and inform treatment decisions.Keywords
Funding Information
- National Institute on Drug Abuse (NCT01825057)
This publication has 67 references indexed in Scilit:
- Physician Detection of Unhealthy Substance Use on Inpatient Teaching and Hospitalist Medical ServicesThe American Journal of Drug and Alcohol Abuse, 2012
- Substance use and motivation: a longitudinal perspectiveThe American Journal of Drug and Alcohol Abuse, 2010
- The role of therapist training in the implementation of psychosocial treatments: A review and critique with recommendationsClinical Psychology Review, 2010
- Physicians’ Implicit and Explicit Attitudes About Race by MD Race, Ethnicity, and GenderJournal Of Health Care For The Poor and Underserved, 2009
- Marijuana and chronic obstructive lung disease: a population-based studyCanadian Medical Association Journal, 2009
- Disparities in Alcohol‐Related Problems Among White, Black, and Hispanic AmericansAlcohol, Clinical and Experimental Research, 2009
- Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: Comparison at intake and 6 months laterDrug and Alcohol Dependence, 2009
- Reducing Racial Bias Among Health Care Providers: Lessons from Social-Cognitive PsychologyJournal of General Internal Medicine, 2007
- The severity of unhealthy alcohol use in hospitalized medical patientsJournal of General Internal Medicine, 2006
- Unmet substance abuse treatment need, health services utilization, and cost: A population-based emergency department studyAnnals of Emergency Medicine, 2005